Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition
Clinical trial NCT04064190 · WITHDRAWN
Trial details
- NCT number
- NCT04064190
- Sponsor
- MedPacto, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2023-12-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.